Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome - A Cross-sectional Study from Bangladesh.

Q2 Medicine European Endocrinology Pub Date : 2020-10-01 Epub Date: 2020-10-06 DOI:10.17925/EE.2020.16.2.156
Abm Kamrul-Hasan, Fatema Tuz Zahura Aalpona, Shahjada Selim
{"title":"Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome - A Cross-sectional Study from Bangladesh.","authors":"Abm Kamrul-Hasan, Fatema Tuz Zahura Aalpona, Shahjada Selim","doi":"10.17925/EE.2020.16.2.156","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Separately, polycystic ovary syndrome (PCOS) and subclinical hypothyroidism (SCH) exert adverse effects on several reproductive and metabolic parameters; however, in conjunction, their effects are unclear. This study evaluated the impact of SCH on reproductive and metabolic parameters in women with PCOS.</p><p><strong>Methods: </strong>In this cross-sectional study, women with newly diagnosed PCOS were evaluated. Data on their clinical presentation and anthropometric measurements were recorded, in addition to oral glucose tolerance test, fasting lipid profile, serum thyroid-stimulating hormone (TSH), free thyroxine (FT4) and anti-thyroid peroxidase (anti-TPO).</p><p><strong>Results: </strong>Four hundred and sixty-five women, aged 12-40 years, with PCOS were included in this study; 10.8% of them had SCH and 18.3% were positive for anti-TPO. All participants had statistically similar mean age, body mass index (BMI), waist circumference, systolic blood pressure (BP) and diastolic BP. A similar number of participants in both the euthyroid PCOS and PCOS-SCH groups had menstrual irregularity, acne, subfertility, a first-degree family member with thyroid dysfunction, acanthosis nigricans and elevated BP. Participants with SCH-PCOS had a lower modified Ferriman-Gallwey score and hirsutism frequency, though serum total testosterone levels were similar in the two groups. More subjects in the SCH group were overweight/obese, and had central obesity and goiter compared to the euthyroid group. Blood glucose, lipids and prolactin levels were similar between the two groups; the frequencies of dysglycaemia and dyslipidaemia were also similar. A higher frequency of metabolic syndrome was observed in the SCH group, though the difference was not statistically significant (p=0.098).</p><p><strong>Conclusion: </strong>In women with PCOS, the presence of SCH does not amplify the risk of metabolic and reproductive dysfunctions.</p>","PeriodicalId":38860,"journal":{"name":"European Endocrinology","volume":"16 2","pages":"156-160"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572170/pdf/euendo-16-156.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/EE.2020.16.2.156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/10/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Separately, polycystic ovary syndrome (PCOS) and subclinical hypothyroidism (SCH) exert adverse effects on several reproductive and metabolic parameters; however, in conjunction, their effects are unclear. This study evaluated the impact of SCH on reproductive and metabolic parameters in women with PCOS.

Methods: In this cross-sectional study, women with newly diagnosed PCOS were evaluated. Data on their clinical presentation and anthropometric measurements were recorded, in addition to oral glucose tolerance test, fasting lipid profile, serum thyroid-stimulating hormone (TSH), free thyroxine (FT4) and anti-thyroid peroxidase (anti-TPO).

Results: Four hundred and sixty-five women, aged 12-40 years, with PCOS were included in this study; 10.8% of them had SCH and 18.3% were positive for anti-TPO. All participants had statistically similar mean age, body mass index (BMI), waist circumference, systolic blood pressure (BP) and diastolic BP. A similar number of participants in both the euthyroid PCOS and PCOS-SCH groups had menstrual irregularity, acne, subfertility, a first-degree family member with thyroid dysfunction, acanthosis nigricans and elevated BP. Participants with SCH-PCOS had a lower modified Ferriman-Gallwey score and hirsutism frequency, though serum total testosterone levels were similar in the two groups. More subjects in the SCH group were overweight/obese, and had central obesity and goiter compared to the euthyroid group. Blood glucose, lipids and prolactin levels were similar between the two groups; the frequencies of dysglycaemia and dyslipidaemia were also similar. A higher frequency of metabolic syndrome was observed in the SCH group, though the difference was not statistically significant (p=0.098).

Conclusion: In women with PCOS, the presence of SCH does not amplify the risk of metabolic and reproductive dysfunctions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
亚临床甲状腺机能减退对多囊卵巢综合征患者生殖和代谢参数的影响--孟加拉国横断面研究。
导言:多囊卵巢综合征(PCOS)和亚临床甲状腺功能减退症(SCH)分别对生殖和代谢指标产生不利影响,但两者同时存在时,其影响尚不明确。本研究评估了亚临床甲状腺功能减退症对多囊卵巢综合征女性生殖和代谢指标的影响:在这项横断面研究中,对新诊断为多囊卵巢综合征的女性进行了评估。除了口服葡萄糖耐量试验、空腹血脂谱、血清促甲状腺激素(TSH)、游离甲状腺素(FT4)和抗甲状腺过氧化物酶(抗-TPO)外,还记录了她们的临床表现和人体测量数据:本研究共纳入 465 名患有多囊卵巢综合征的女性,年龄在 12-40 岁之间,其中 10.8%患有 SCH,18.3%呈抗-TPO 阳性。所有参与者的平均年龄、体重指数(BMI)、腰围、收缩压和舒张压在统计学上相似。在甲状腺功能正常的多囊卵巢综合症组和多囊卵巢综合症-SCH 组中,月经不调、痤疮、不孕、一级亲属中有甲状腺功能障碍、黑棘皮症和血压升高的人数相似。SCH-多囊卵巢综合征患者的改良费里曼-高韦氏评分和多毛症频率较低,但两组患者的血清总睾酮水平相似。与甲状腺功能正常组相比,SCH 组中超重/肥胖、中心性肥胖和甲状腺肿大的受试者更多。两组受试者的血糖、血脂和催乳素水平相似;出现血糖异常和血脂异常的频率也相似。SCH 组出现代谢综合征的频率较高,但差异无统计学意义(P=0.098):结论:在患有多囊卵巢综合症的妇女中,SCH 的存在不会增加代谢和生殖功能障碍的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Endocrinology
European Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
期刊最新文献
ADA-EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective. Clinical Profile and Factors Associated with Adverse Outcomes in Coronavirus Disease 2019-associated Mucormycosis: A Single-centre Study. What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review. Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the Horizon. Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1